title: Obesity pharmacotherapy: what is next?
abstract: The increase in obesity in the Unites States and around the world in the last decade is overwhelming. The number of overweight adults in the world surpassed 1 billion in 2008. Health hazards associated with obesity are serious and include heart disease, sleep apnea, diabetes, and cancer. Although lifestyle modifications are the most straightforward way to control weight, a large portion of the population may not be able to rely on this modality alone. Thus, the development of anti-obesity therapeutics represents a major unmet medical need. Historically, anti-obesity pharmacotherapies have been unsafe and minimally efficacious. A better understanding of the biology of appetite and metabolism provides an opportunity to develop drugs that may offer safer and more effective alternatives for weight management. This review discusses drugs that are currently on the market and in development as anti-obesity therapeutics based on their target and mechanism of action. It should serve as a roadmap to establish expectations for the near future for anti-obesity drug development.
authors.affiliation: Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA, United States. Francheska.Colon-Gonzalez@jefferson.edu
authors.forename: Francheska
authors.initials: F
authors.lastname: Colon-Gonzalez
authors.forename: Gilbert W
authors.initials: GW
authors.lastname: Kim
authors.forename: Jieru E
authors.initials: JE
authors.lastname: Lin
authors.forename: Michael A
authors.initials: MA
authors.lastname: Valentino
authors.forename: Scott A
authors.initials: SA
authors.lastname: Waldman
mesh_terms: D019440:Anti-Obesity Agents / Q000494:pharmacology*; D001066:Appetite / Q000187:drug effects; D016503:Drug Delivery Systems; D006801:Humans; D008019:Life Style; D008049:Lipase / Q000037:antagonists & inhibitors / Q000378:metabolism; D009479:Neuropeptides / Q000378:metabolism; D009765:Obesity / Q000188:drug therapy*; D010187:Pancreatic Hormones / Q000378:metabolism; D009435:Synaptic Transmission / Q000187:drug effects; D015431:Weight Loss / Q000187:drug effects
chemical_list: D019440:Anti-Obesity Agents; D009479:Neuropeptides; D010187:Pancreatic Hormones; D008049:Lipase